Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study.
Aaron P MitchellStacie B DusetzinaAkriti Mishra MezaNiti U TrivediAaron N WinnAaron N WinnPublished in: BMJ (Clinical research ed.) (2023)
Within some clinical scenarios, industry payments to physicians are associated with non-recommended and low value drugs. These findings raise quality of care concerns about the financial relationships between physicians and industry.